About PhRMA
The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research companies, which are laser focused on developing innovative medicines that transform lives and create a healthier world. Together, we are fighting for solutions to ensure patients can access and afford medicines that prevent, treat and cure disease. Over the last decade, PhRMA member companies have invested more than $850 billion in the search for new treatments and cures, and they support nearly five million jobs in the United States.
Connect with PhRMA
For information on how innovative medicines save lives, please visit:
www.PhRMA.org
www.VotersforCures.org
www.AmericasMedicines.com
www.Facebook.com/PhRMA
www.X.com/PhRMA
On January 14, Chief Public Affairs Officer & Head of Strategic Initiatives, Robert Zirkelbach, participated in Fierce JPM Week. During the interview, Robby discussed the incredible promise we’re seeing in biopharmaceutical innovation. He also discussed how we need strong IP protections, a predictable regulatory environment, incentives for collaboration and a competitive marketplace that brings down costs to get these treatments into the hands of patients.
When:
Tuesday, January 14, 2025
Speakers:
- Robert Zirkelbach, Chief Public Affairs Officer & Head of Strategic Initiatives, PhRMA
- Rebecca Willumson, SVP & Publisher, Fierce Life Sciences and Healthcare (Moderator)